HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chitra M Hosing Selected Research

FM 100 (FM100)

1/2019Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
10/2013A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chitra M Hosing Research Topics

Disease

7Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 08/2013
5Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 02/2009
5Multiple Myeloma
01/2020 - 05/2012
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019 - 02/2009
4Hodgkin Disease (Hodgkin's Disease)
01/2016 - 02/2009
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2017 - 02/2009
3Infections
06/2017 - 02/2009
3Neoplasms (Cancer)
06/2017 - 05/2010
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 11/2013
2Lymphoma (Lymphomas)
01/2019 - 01/2017
1COVID-19
12/2021
1Philadelphia Chromosome
10/2020
1Idiopathic Noncirrhotic Portal Hypertension
01/2020
1Ascites
01/2020
1Portal Hypertension
01/2020
1Weight Gain
12/2017
1Cytokine Release Syndrome
01/2017
1Nausea
01/2016
1Pathologic Complete Response
01/2016
1Virus Diseases (Viral Diseases)
10/2013
1Disease Progression
10/2013
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2013
1Hepatitis
05/2010
1Hepatitis B
05/2010
1Primary Myelofibrosis (Myelosclerosis)
04/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2009
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2009

Drug/Important Bio-Agent (IBA)

7Melphalan (Alkeran)FDA LinkGeneric
01/2019 - 03/2012
5fludarabineIBA
12/2019 - 03/2012
3SteroidsIBA
01/2022 - 01/2018
2Busulfan (Busulfex)FDA Link
12/2019 - 12/2017
2FM 100 (FM100)IBA
01/2019 - 10/2013
2Antiviral Agents (Antivirals)IBA
06/2017 - 10/2013
2GemcitabineFDA Link
01/2016 - 03/2012
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2021
1Tacrolimus (Prograf)FDA LinkGeneric
12/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021
1carboxyl radical (COO-)IBA
01/2021
1AlbuminsIBA
01/2020
1Pentostatin (Nipent)FDA LinkGeneric
01/2018
1axicabtagene ciloleucelIBA
01/2017
1Brentuximab VedotinIBA
01/2016
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2014
1pidilizumabIBA
11/2013
1CD19-specific chimeric antigen receptorIBA
10/2013
1Viral AntigensIBA
10/2013
1Bortezomib (Velcade)FDA Link
05/2012
1Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2010
1Surface Antigens (Surface Antigen)IBA
05/2010
1BilirubinIBA
02/2009
1Alanine Transaminase (SGPT)IBA
02/2009

Therapy/Procedure

7Hematopoietic Stem Cell Transplantation
01/2020 - 02/2009
5Stem Cell Transplantation
01/2020 - 04/2010
4Transplantation
12/2021 - 12/2014
4Therapeutics
01/2021 - 01/2016
2Autologous Transplantation
01/2021 - 11/2019
2Cell Transplantation
10/2020 - 06/2017
1Catheters
01/2020
1Homologous Transplantation
01/2019
1Haploidentical Transplantation
12/2017
1Photopheresis
08/2013
1Induction Chemotherapy
04/2010